About the Authors
- James Lu
-
* E-mail: james.lu.jl1@roche.com
Affiliation F. Hoffmann-La Roche AG, pRED, Pharma Research & Early Development, Clinical Pharmacology, Basel, Switzerland
- Katrin Hübner
-
Affiliation BioQuant, University of Heidelberg, Heidelberg, Germany
- M. Nazeem Nanjee
-
Affiliation Division of Cardiovascular Genetics, University of Utah, Salt Lake City, Utah, United States of America
- Eliot A. Brinton
-
Affiliation Utah Foundation for Biomedical Research, Salt Lake City, Utah, United States of America
- Norman A. Mazer
-
Affiliation F. Hoffmann-La Roche AG, pRED, Pharma Research & Early Development, Clinical Pharmacology, Basel, Switzerland
Competing Interests
I have read the journal's policy and have the following conflicts: JL and NAM are employees of F. Hoffmann-La Roche; JL and NAM have stock ownership of F. Hoffmann-La Roche. KH, MNN and EAB declare no competing interest.
Author Contributions
Analyzed the data: JL NAM. Contributed reagents/materials/analysis tools: JL NAM. Wrote the paper: JL KH MNN EAB NAM.